{
    "2020-07-27": [
        [
            {
                "time": "",
                "original_text": "小摩减持康龙化成(03759)38.84万股，每股作价约89.58港元",
                "features": {
                    "keywords": [
                        "小摩",
                        "减持",
                        "康龙化成",
                        "港股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "在A股打拼了近8年、高瓴资本热捧的泰格医药于7月19日通过了港交所聆讯，据传本周将开始招股。大家都说泰格医药是国内CRO(药物研发外包服务)龙头企业，但为什么还称泰格为国内CRO龙头企业呢？另外，泰格医药有什么过人之处让高瓴资本两次购买其股份呢？",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "高瓴资本",
                        "CRO",
                        "龙头企业",
                        "港股上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本再次加仓的泰格医药是一家什么样的企业?",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "加仓",
                        "泰格医药"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}